University of Miami Sylvester Comprehensive Cancer Center

 

AML Biology and Treatment
20:35

University of Miami's 2nd Biennial Miami Leukemia Symposium

Curing APL in 2020: Have We Completely Deciphered Mechanism(s) of Coagulopathy? Should Pts Be Treated Differently According to Their Bleeding Risk? Should We Revisit Heparin?

FEATURING Martin Tallman
  • 61 views
  • October 23, 2020
16:42

University of Miami's 2nd Biennial Miami Leukemia Symposium

IDH Inhibitors in Myeloid Malignancies: What Are the Mechanisms of Resistance in R/R AML? What Are the Strategies to Combine IDH Inhibitors With SoC?

FEATURING Eytan Stein
  • 228 views
  • May 14, 2020
  • 1
20:28

University of Miami's 2nd Biennial Miami Leukemia Symposium

Tailoring Therapies to Target Leukemia Stem Cells: PU-FITC Binding Assay Could Be Utilized to Select Patients That Are More Likely to Respond to Treatment With PUH71

FEATURING Monica Guzman
  • 23 views
  • May 14, 2020
23:05

University of Miami's 2nd Biennial Miami Leukemia Symposium

Venetoclax Can Effectively Target AML Stem Cells Through Acid-Fueled OXPHOS, AML M5 Is a Risk Factor for Lack of Response to Venetoclax

FEATURING Daniel Pollyea
  • 30 views
  • May 14, 2020